These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 26721675)
61. Distinct Signaling Roles of cIMP, cCMP, and cUMP. Seifert R Structure; 2016 Oct; 24(10):1627-1628. PubMed ID: 27705814 [TBL] [Abstract][Full Text] [Related]
62. Cardioprotection - is no the answer? A renewed look at nitric oxide signalling in cardiomyocytes. Davidson SM; Yellon DM Cardiovasc Res; 2018 May; 114(6):773-775. PubMed ID: 29584817 [No Abstract] [Full Text] [Related]
63. cCMP and cUMP come into the spotlight, finally. Seifert R; Schirmer B Trends Biochem Sci; 2022 Jun; 47(6):461-463. PubMed ID: 35031198 [TBL] [Abstract][Full Text] [Related]
64. What can we learn from SOCRATES: more questions than answers? Cleland JGF; Mueller C Eur Heart J; 2017 Apr; 38(15):1128-1131. PubMed ID: 28204466 [No Abstract] [Full Text] [Related]
65. [The metabolic activity of the vascular wall]. COMEL M Rass Clin Sci; 1962 Mar; 38():69-73. PubMed ID: 13880753 [No Abstract] [Full Text] [Related]
66. Putative Nucleotide-Based Second Messengers in the Archaeal Model Organisms Braun F; Recalde A; Bähre H; Seifert R; Albers SV Front Microbiol; 2021; 12():779012. PubMed ID: 34880846 [TBL] [Abstract][Full Text] [Related]
67. Involvement of 3',5'-cyclic inosine monophosphate in cystathionine γ-lyase-dependent regulation of the vascular tone. Mitidieri E; Vellecco V; Brancaleone V; Vanacore D; Manzo OL; Martin E; Sharina I; Krutsenko Y; Monti MC; Morretta E; Papapetropoulos A; Caliendo G; Frecentese F; Cirino G; Sorrentino R; d'Emmanuele di Villa Bianca R; Bucci M Br J Pharmacol; 2021 Sep; 178(18):3765-3782. PubMed ID: 33931865 [TBL] [Abstract][Full Text] [Related]
68. PDE1 or PDE5 inhibition augments NO-dependent hypoxic constriction of porcine coronary artery via elevating inosine 3',5'-cyclic monophosphate level. Nan Y; Zeng X; Jin Z; Li N; Chen Z; Chen J; Wang D; Wang Y; Lin Z; Ying L J Cell Mol Med; 2020 Dec; 24(24):14514-14524. PubMed ID: 33169529 [TBL] [Abstract][Full Text] [Related]
69. Nitric Oxide: From Good to Bad. Vanhoutte PM Ann Vasc Dis; 2018 Mar; 11(1):41-51. PubMed ID: 29682106 [TBL] [Abstract][Full Text] [Related]
70. cIMP synthesized by sGC as a mediator of hypoxic contraction of coronary arteries. Chen Z; Zhang X; Ying L; Dou D; Li Y; Bai Y; Liu J; Liu L; Feng H; Yu X; Leung SW; Vanhoutte PM; Gao Y Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H328-36. PubMed ID: 24906916 [TBL] [Abstract][Full Text] [Related]
71. Conventional and Unconventional Mechanisms for Soluble Guanylyl Cyclase Signaling. Gao Y J Cardiovasc Pharmacol; 2016 May; 67(5):367-72. PubMed ID: 26452163 [TBL] [Abstract][Full Text] [Related]
73. cCMP, cUMP, cTMP, cIMP and cXMP as possible second messengers: development of a hypothesis based on studies with soluble guanylyl cyclase α(1)β(1). Beste KY; Seifert R Biol Chem; 2013 Feb; 394(2):261-70. PubMed ID: 23087103 [TBL] [Abstract][Full Text] [Related]
74. 3',5'-cIMP as Potential Second Messenger in the Vascular Wall. Leung SWS; Gao Y; Vanhoutte PM Handb Exp Pharmacol; 2017; 238():209-228. PubMed ID: 26721675 [TBL] [Abstract][Full Text] [Related]